Release Date: 31/01/13 18:10 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 769.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%